Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 1661-1670 of 2862 for cancer

Edit search filters
  1. A Study To Assess Accelerated Resolution Therapy For Cancer Related Trauma And Distress

    Jacksonville, FL, Rochester, MN

  2. Apixaban Or Dalteparin In Reducing Blood Clots In Patients With Cancer Related Venous Thromboembolism

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  3. Radiation Therapy in Treating Patients With Extensive Stage Small Cell Lung Cancer

    La Crosse, WI

  4. A Solid Tumor Study For Long Term Treatment Of Cancer Patients Who Participated In Adagrasib Studies

    Rochester, MN

  5. Stereotactic Adaptive Radiation Therapy Of Borderline Resectable Pancreatic Cancer An Individualized Approach

    Rochester, MN

  6. A Study To Evaluate Androgen-Deprivation Therapy And Radiation Therapy In Treating Patients With Prostate Cancer

    Eau Claire, WI

  7. Neratinib +/- Fulvestrant In Metastatic HER2 Non-amplified But HER2 Mutant Breast Cancer

    Rochester, MN

  8. Olanzapine For The Treatment Of Chronic Nausea And/or Vomiting In Advanced Cancer Patients

    Rochester, MN

  9. Capecitabine And Bevacizumab With Or Without Atezolizumab In Treating Patients With Refractory Metastatic Colorectal Cancer

    Scottsdale/Phoenix, AZ, Rochester, MN

  10. Stress Management And Resilience Training (SMART) Intervention For Family Caregivers Of Individuals With Advanced Cancer

    Rochester, MN

.

Mayo Clinic Footer